Your browser doesn't support javascript.
loading
CYP2C19 Genotype is an Independent Predictor of Adverse Cardiovascular Outcome in Iraqi Patients on Clopidogrel After Percutaneous Coronary Intervention.
Mohammad, Ameen M; Al-Allawi, Nasir A S.
Affiliation
  • Al-Allawi NAS; Pathology, College of Medicine, University of Duhok, Kurdistan, Iraq.
J Cardiovasc Pharmacol ; 71(6): 347-351, 2018 06.
Article in En | MEDLINE | ID: mdl-29554005
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Drug Resistance / Platelet Aggregation Inhibitors / Percutaneous Coronary Intervention / Cytochrome P-450 CYP2C19 / Pharmacogenomic Variants / Clopidogrel Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: J Cardiovasc Pharmacol Year: 2018 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Drug Resistance / Platelet Aggregation Inhibitors / Percutaneous Coronary Intervention / Cytochrome P-450 CYP2C19 / Pharmacogenomic Variants / Clopidogrel Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: J Cardiovasc Pharmacol Year: 2018 Document type: Article Country of publication: